Tagged with P

Switzerland Dr Daniel Roth outlines his long-standing career with Menarini Group, its strategic evolution in Switzerland, and the broader challenges facing the healthcare industry. Dr Roth emphasizes the importance of building strong teams, the role of entrepreneurial freedom in shaping local strategies, and Switzerland’s unique position in the global healthcare landscape.…

Italy The top 10 pharma manufacturing companies in Italy, as collated by MonitorItalia and ranked by production value in 2022. Pfizer tops the list, followed by Novartis, and local player Chiesi. The remainder of the list is populated by familiar names from multinational pharma, although another Italian firm – Alfasigma –…

USA As Breast Cancer Awareness Month 2024 draws to a close, PhRMA’s Elizabeth Carpenter lays out the massive progress made in breast cancer treatment outcomes over the past half-century. However, Carpenter warns that further progress in breast cancer R&D is under threat, highlighting three key policy barriers that must be removed…

Germany The latest news from German pharma, including why Merck KGaA is looking to life science M&A; positive outlooks for Bayer and STADA; BioNTech’s move into the AI lab assistant space with Google DeepMind; and the recipe to fix the country’s ailing healthcare system.   Germany’s Merck open to more M&A…

Global Pfizer CEO Albert Bourla’s ‘annus horribilis’ shows no sign of abating. From being feted as the industry darling of the COVID-19 period, Pfizer management is now being accused of USD 20 billion worth of “value destruction” by activist investors. As new analysis shows, Bourla has also suffered the ignominy of…

Switzerland Dr Michael Quirmbach of CordenPharma discusses the company’s ambitious goal to become one of the top five CDMOs globally, emphasizing the importance of strong scientific expertise and customer-centricity in their operations. Dr Quirmbach highlights the significance of adapting to market demands and maintaining high compliance standards while fostering strategic partnerships.…

USA Naming a Chief Artificial Intelligence (AI) officer may not be an industry first, but Lilly’s recent creation of the role with the appointment of Thomas Fuchs confirms the solid commitment pharma has already made to introducing AI in processes that range from drug discovery to marketing.   AI Leaders Eli…

Mexico Cecilia Moreno, from the PPD™ clinical research business of Thermo Fisher Scientific, highlights Mexico’s growing role in clinical research, supported by regulatory advancements and a skilled workforce. Moreno emphasizes the potential for expanding clinical trials in Mexico, enhancing patient access to innovative therapies, and leveraging the country’s strategic advantages in…

USA Monica Weldon, a seasoned rare disease patient advocate in the US, now serves as the lead strategic analyst for the life science industry base policy at Leidos, a technology solutions firm. Here, she explains the rationale behind the Biden administration’s Executive Order 14081 from 2022, as well as its impact…

Mexico Sworn in this month as Mexico’s first female president, Claudia Sheinbaum has pledged “continuity with change,” with respect to her predecessor Andrés Manuel López Obrador’s policies. While she has promised to drive forward the healthcare reforms López Obrador introduced – namely universal coverage – she has also set out a…

India Contributing to the October 2024 edition of DIA’s Global Forum magazine, Stephanie Rosner of DIA and Martin Hodosi and Rosanna Lim of Kearney highlight the discussions from DIA’s multistakeholder Responsible AI Solution Room, which focused on cross-sector partnerships for responsible AI use and strategies to mitigate AI risk.   Artificial…

Global In the October 2024 edition of DIA’s Global Forum magazine, Global Forum founding Editor-in-Chief and former DIA board member Andrzej Czarnecki of Eli Lilly and Company shares his reflections on DIA’s 60-year anniversary and prospects for the future with his successor, current Editor-in-Chief Alberto Grignolo.   Alberto Grignolo (DIA): Andrzej,…